Grants and Contributions:
Title:
Multiplex assessment of the level of IgG antibodies in human serum samples against SARS-CoV-2.
Agreement Number:
930181
Agreement Value:
$199,884.00
Agreement Date:
Jun 24, 2019 - Dec 18, 2020
Description:
Develop a multiplex assay to measure the immune response to the nine prevalent HPV types.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Laval, Quebec, CA H7V 3S8
Reference Number:
172-2019-2020-Q2-930181
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
738323518
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by -38 days. The total amended value is 65,184 dollars.
Amendment Date
Nov 4, 2020
Recipient's Operating Name:
LABORATOIRES NEXELIS CANADA INC.
Recipient's Legal Name:
NEXELIS LABORATORIES CANADA INC.
Federal Riding Name:
Vimy
Federal Riding Number:
24078
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: